539 related articles for article (PubMed ID: 26973412)
1. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
Sarkar A; De R; Mukhopadhyay AK
World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
[TBL] [Abstract][Full Text] [Related]
2. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases.
Mohammadi A; Khanbabaei H; Zandi F; Ahmadi A; Haftcheshmeh SM; Johnston TP; Sahebkar A
Microb Pathog; 2022 May; 166():105552. PubMed ID: 35469998
[TBL] [Abstract][Full Text] [Related]
3. Review: Pharmacological ins and outs of medicinal plants against Helicobacter pylori: A review.
Zaidi SF; Muhammad JS; Usmanghani K; Sugiyama T
Pak J Pharm Sci; 2015 May; 28(3 Suppl):1171-6. PubMed ID: 26051742
[TBL] [Abstract][Full Text] [Related]
4. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
[TBL] [Abstract][Full Text] [Related]
5. Chemoprevention for gastric cancer.
Ford AC
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):581-92. PubMed ID: 22122773
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Koosirirat C; Linpisarn S; Changsom D; Chawansuntati K; Wipasa J
Int Immunopharmacol; 2010 Jul; 10(7):815-8. PubMed ID: 20438867
[TBL] [Abstract][Full Text] [Related]
7. Curcumin blocks NF-kappaB and the motogenic response in Helicobacter pylori-infected epithelial cells.
Foryst-Ludwig A; Neumann M; Schneider-Brachert W; Naumann M
Biochem Biophys Res Commun; 2004 Apr; 316(4):1065-72. PubMed ID: 15044093
[TBL] [Abstract][Full Text] [Related]
8. Non-microbial approach for Helicobacter pylori as faster track to prevent gastric cancer than simple eradication.
Park SH; Kangwan N; Park JM; Kim EH; Hahm KB
World J Gastroenterol; 2013 Dec; 19(47):8986-95. PubMed ID: 24379623
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Helicobacter pylori and prevention of gastric cancer.
Cheung TK; Wong BC
J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin and its derivatives prevent Helicobacter pylori-induced gastric carcinogenesis via inhibition of NF-κB signaling.
Su T; Li F; Guan J; Liu L; Huang P; Wang Y; Qi X; Liu Z; Lu L; Wang D
Phytomedicine; 2019 Oct; 63():152968. PubMed ID: 31280140
[TBL] [Abstract][Full Text] [Related]
11. The eradication of Helicobacter pylori to prevent gastric cancer: a critical appraisal.
Wu JY; Lee YC; Graham DY
Expert Rev Gastroenterol Hepatol; 2019 Jan; 13(1):17-24. PubMed ID: 30791844
[TBL] [Abstract][Full Text] [Related]
12. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A
Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004
[TBL] [Abstract][Full Text] [Related]
13. [The "stomach evil" Helicobacter pylori: also stomach cancer is usually accredited to Helicobacter pylori].
MMW Fortschr Med; 2004 Jun; 146(24):54. PubMed ID: 15366502
[No Abstract] [Full Text] [Related]
14. The antibacterial effect of fatty acids on Helicobacter pylori infection.
Jung SW; Lee SW
Korean J Intern Med; 2016 Jan; 31(1):30-5. PubMed ID: 26767854
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori infection, gastrin and cyclooxygenase-2 in gastric carcinogenesis.
Shao Y; Sun K; Xu W; Li XL; Shen H; Sun WH
World J Gastroenterol; 2014 Sep; 20(36):12860-73. PubMed ID: 25278683
[TBL] [Abstract][Full Text] [Related]
16. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review.
Boyanova L; Medeiros J; Yordanov D; Gergova R; Markovska R
Lett Appl Microbiol; 2024 Jun; 77(6):. PubMed ID: 38794899
[TBL] [Abstract][Full Text] [Related]
17. Turmeric (Curcuma longa) and curcumin inhibit the growth of Helicobacter pylori, a group 1 carcinogen.
Mahady GB; Pendland SL; Yun G; Lu ZZ
Anticancer Res; 2002; 22(6C):4179-81. PubMed ID: 12553052
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK
Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.
Vogiatzi P; Cassone M; Luzzi I; Lucchetti C; Otvos L; Giordano A
J Cell Biochem; 2007 Oct; 102(2):264-73. PubMed ID: 17486575
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: A review.
Asano N; Iijima K; Koike T; Imatani A; Shimosegawa T
World J Gastroenterol; 2015 Jul; 21(26):8014-20. PubMed ID: 26185372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
